Hemostasis Valve Market Size, Share, Growth Report 2030

The global Hemostasis Valve market is slated to accrue revenue worth nearly 222.48 (USD Million) by 2026 and record the CAGR of about 5.98% over the period from 2020 to 2026. The report offers assessment and analysis of the Hemostasis Valve market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, sales estimates, opportunities, evolving trends, and industry-validated data. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).

Introduction

Hemostasis valve is regularly utilized in neuroendovascular surgeries for reducing the thromboembolism risk. Moreover, new kinds of hemostasis valves referred as guardian hemostasis valves were introduced in the first decade of the twenty-first century for minimizing the blood loss in patients.

Additionally, hemostasis valves helps healthcare providers in raising the proficiency of next-generation catheter as well as delivery systems. Investors in the hemostasis valves industry are investing massively in research activities for creating new medical devices with innovative designs that can fulfill the consumer requirements & necessities.

Details of the Report:

Market Growth Dynamics

Surge in the number of interventional surgical methods, a prominent rise in hospitals & clinics, and rise in the aging population prone to heart or cardiac disorders is likely to drive the growth of the hemostasis valve over the forecast period. Moreover, hemostasis valves are used on the large-scale in interventional surgical procedures like percutaneous transluminal coronary angioplasty for reducing the loss of blood after interventional instrument insertion in human vasculature.  A prominent bulge in incidences of heart disorders has resulted in a steep increase of endovascular surgeries, thereby driving the market trends.  

Furthermore, introduction of new products by the market players and strategic business strategies like product innovation are likely to steer the growth of the market over the forthcoming years. Inactive lifestyle and rise in the cases of obesity across the globe is expected to chart a profitable roadmap for hemostasis valve over the years to come.

North America To Account For Major Market Share By 2026

The regional market growth over the forecast period is attributed to massive inflation in geriatric population, increase in the number of coronary artery ailments, and rise in the proportion of interventional surgeries in the countries like the U.S. and Canada.  Moreover, huge presence of giant players in the countries like the U.S. will further prompt the business growth over the forthcoming years. Availability of advanced healthcare infrastructure facilities and high disposable incomes are likely to define the growth of the hemostasis valve industry in North American sub-continent.

Key players profiled in the report are Minivalve, Merit Medical, GaltNeedleTech, Ambu, St. Jude Medical, Teleflex, B. Braun, Qosina, Excel Medical Products, Abbott, Armstrong Medical, and Ceodeux Meditec.

The global Hemostasis Valve Market is segmented as follows:

By Type

• Hemostasis Valve Y-connectors
• Double Y-connector Hemostasis Valves
• One-handed Hemostasis Valves
• Other Hemostasis Valves

By Application

• Angiography
• Angioplasty

By End-User

• Hospitals
• Other End Users

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa